Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-23T16:08:40.877Z Has data issue: false hasContentIssue false
  • English
  • Français

Factors influencing non-adherence to radiotherapy: a retrospective audit of 1,548 patients from a tertiary cancer centre

Published online by Cambridge University Press:  20 November 2019

Vijay Palwe Open the ORCID record for Vijay Palwe [Opens in a new window] ,
Roshankumar Patil Open the ORCID record for Roshankumar Patil [Opens in a new window] ,
Prakash Pandit Open the ORCID record for Prakash Pandit [Opens in a new window]  and
Rajnish Nagarkar Open the ORCID record for Rajnish Nagarkar [Opens in a new window]
Vijay Palwe
Affiliation:
1 Department of Radiation Oncology, HCG Manavata Cancer Centre, Nashik, Maharashtra, India
Roshankumar Patil*
Affiliation:
1 Department of Radiation Oncology, HCG Manavata Cancer Centre, Nashik, Maharashtra, India
Prakash Pandit
Affiliation:
1 Department of Radiation Oncology, HCG Manavata Cancer Centre, Nashik, Maharashtra, India
Rajnish Nagarkar
Affiliation:
2 Department of Surgical Oncology, HCG Manavata Cancer Centre, Nashik, Maharashtra, India
*
Author for correspondence: Dr. Roshankumar Patil, Department of Radiation Oncology, HCG Manavata Cancer Centre, Nashik 422011, Maharashtra, India. Mobile: +91 9819021567. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Purpose:

To determine the frequency, factors and reasons of patient non-adherence to radiotherapy (RT) in a tertiary cancer centre.

Background:

Inadvertent treatment interruptions often lead to prolongation of planned treatment time. In the case of RT with a curative intent, prolongation of planned treatment has been associated with inferior clinical outcomes. Delay or prolongation of treatment is associated with a relative risk of local recurrence by up to 2% per day for specific malignancies. Thus, it is critical to understand key factors that influence non-adherence to RT.

Methods and Materials:

A retrospective observation audit was conducted comprising patients treated with radical, adjuvant or palliative RT at our centre from January 2018 to December 2018. Non-adherence was defined as premature permanent termination of planned treatment by the patient without recommendation or consultation from the treating clinician. All data were collected and analysed (retrospectively) with the help of Statistical Package for the Social Sciences (SPSS) version 22.

Results:

A total of 1,548 patients were included in the study of which 105 (6·7%) were non-adherent to planned RT. Of the total 105 patients, 44 (42%) were elderly (60 years and above). Treatment non-adherence was predominant in males (male:female = 1·85:1). More than 90% of non-adherent patients had stage III and IV cancer. A total of 77 patients (74%) out of 105 were more than 50 km away from our centre. A total of 66 (63%) out of 105 patients had completed more than 2 weeks of radiation (40% of planned RT) and then defaulted for radiation due to acute toxicities.

Conclusion:

Treatment adherence is a major factor in determining successful outcomes among cancer patients treated with RT. This study reveals several factors that contribute to non-adherence to treatment.

Keywords

cancer carecomplianceincomplete treatmentnon-adherenceradiotherapysurvival
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 19 , Issue 4 , December 2020 , pp. 359 - 364
Check for updates
Copyright
© Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Potters, L, Raince, J, Chou, H et al. Development, implementation, and compliance of treatment pathways in radiation medicine. Front Oncol 2013; 3: 105.CrossRefGoogle ScholarPubMed
Rudat, V, Nour, A, Hammoud, M, AbouGhaida, S. Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy: results of a single, institutional, retrospective study. Strahlenther Onkol 2017; 193 (5): 375–384.CrossRefGoogle ScholarPubMed
Bese, N S, Hendry, J, Jeremic, B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J RadiatOncolBiol Phys 2007; 68 (3): 654–661.Google ScholarPubMed
Habibi, M, Namimoghadam, A, Korouni, R et al. Radiation-induced nausea and vomiting: is ABO blood group as important as radiation and patient-related factors? An observational study. Medicine (Baltimore) 2016; 95 (31): e4334.CrossRefGoogle ScholarPubMed
Wei, J, Meng, L, Hou, X et al. Radiation-induced skin reactions: mechanism and treatment. Cancer Manag Res 2018; 11: 167–177.CrossRefGoogle ScholarPubMed
Janowski, E M, Kole, T P, Chen, L N et al. Dysuria following stereotactic body radiation therapy for prostate cancer. Front Oncol 2015; 5: 151.CrossRefGoogle ScholarPubMed
Ursino, S, Seccia, V, Cocuzza, P et al. Qual è l’effetto della radioterapia sulla funzionalità deglutitoria nei pazienti con tumore del rinofaringe e orofaringe? Risultati a breve termine di uno studio prospettico [How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study]. Acta Otorhinolaryngol Ital 2016; 36 (3): 174–184.Google Scholar
Stacey, R, Green, J T. Radiation-induced small bowel disease: latest developments and clinical guidance. Ther Adv Chronic Dis 2014; 5 (1): 15–29.CrossRefGoogle ScholarPubMed
Shadad, A K, Sullivan, F J, Martin, J D, Egan, L J. Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol 2013; 19 (2): 185–198.CrossRefGoogle ScholarPubMed
Koom, W S, Ahn, S D, Song, S Y et al. Nutritional status of patients treated with radiotherapy as determined by subjective global assessment. Radiat Oncol J 2012; 30 (3): 132–139.CrossRefGoogle ScholarPubMed
Kaur, J, Mohanti, B K, Muzumder, S. Clinical audit in radiation oncology: results from one academic centre in Delhi, India. Asian Pac J Cancer Prev 2013; 14 (5): 2829–2834.CrossRefGoogle ScholarPubMed
Gupta, S, Rastogi, K, Bhatnagar, A R, Singh, D, Gupta, K, Choudhary, A S. Compliance to radiotherapy: a tertiary care center experience. Indian J Cancer 2018; 55: 166–169.Google ScholarPubMed
Elsner, K, Naehrig, D, Halkett, G K B, Dhillon, H M. Reduced patient anxiety as a result of radiation therapist-led psychosocial support: a systematic review. J Med Radiat Sci 2017; 64 (3): 220–231.CrossRefGoogle ScholarPubMed
Matsuyama, R K, Lyckholm, L J, Molisani, A, Moghanaki, D. The value of an educational video before consultation with a radiation oncologist. J Cancer Educ 2013; 28 (2): 306–313.CrossRefGoogle ScholarPubMed
Halkett, G, O’Connor, M. What is the best way to support patients undergoing radiation therapy? J Med Radiat Sci 2015; 62 (1): 3–5.CrossRefGoogle ScholarPubMed
Riedl, D, Gastl, R, Gamper, E et al. Der Wunsch der Krebspatienten nach psychoonkologischer Unterstützung während der ambulanten Strahlentherapie : Ergebnisse eines psychoonkologischen Monitoringprogramms in der klinischen Routine [Cancer patients’ wish for psychological support during outpatient radiation therapy: findings from a psychooncological monitoring program in clinical routine]. Strahlenther Onkol 2018; 194 (7): 655–663.CrossRefGoogle Scholar
Withers, H R. Biologic basis for altered fractionation schemes. Cancer 1985; 55: 2086–2095.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Withers, H R. Radiation biology and treatment options in radiation oncology. Cancer Res 1999; 59: 1676s–1684s.Google ScholarPubMed
Bernier, J, Horiot, JC. Altered-fractionated radiotherapy in locally advanced head and neck cancer. Curr Opin Oncol 2012; 24: 223–228.CrossRefGoogle ScholarPubMed
Barendsen, G W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 779–790.CrossRefGoogle ScholarPubMed
Withers, H R, Taylor, J M, Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–146.CrossRefGoogle ScholarPubMed
Yang, J, Yue, J B, Liu, J, Yu, J M. Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review). Oncol Lett 2014; 7: 1755–1760.CrossRefGoogle Scholar
Gupta, S, Rastogi, K, Bhatnagar, A R, Singh, D, Gupta, K, Choudhary, A S. Compliance to radiotherapy: a tertiary care center experience. Indian J Cancer 2018; 55: 166–169.Google ScholarPubMed
Vigneswaran, N, Williams, M D. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral MaxillofacSurgClin North Am 2014; 26 (2): 123–141.CrossRefGoogle ScholarPubMed
Mishra, A, Meherotra, R. Head and neck cancer: global burden and regional trends in India. Asian Pac J Cancer Prev 2014; 15 (2): 537–550.CrossRefGoogle ScholarPubMed
Ohri, N, Rapkin, B D, Guha, C, Kalnicki, S, Garg, M. Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center. Int J Radiat Oncol Biol Phys 2016; 95 (2): 563–570.CrossRefGoogle Scholar
Joshi, P, Dutta, S, Chaturvedi, P, Nair, S. Head and neck cancers in developing countries. Rambam Maimonides Med J 2014; 5 (2): e0009.CrossRefGoogle ScholarPubMed
Francis, D. Trends in incidence of head and neck cancers in India. Eur J Cancer 2018; 92: S23.CrossRefGoogle Scholar
Pandey, K C, Revannasiddaiah, S, Pant, N K. Evaluation of factors in relation with the non-compliance to curative intent radiotherapy among patients of head and neck carcinoma: a study from the Kumaon Region of India. Indian J Palliat Care 2015; 21 (1): 21–26.Google ScholarPubMed
Mohanti, B K, Nachiappan, P, Pandey, R M, Sharma, A, Bahadur, S, Thakar, A. Analysis of 2167 head and neck cancer patients’ management, treatment compliance and outcomes from a regional cancer centre, Delhi, India. J Laryngol Otol 2007; 121: 49–56.CrossRefGoogle ScholarPubMed
Sharma, A, Madan, R, Kumar, R et al. Compliance to therapy–elderly head and neck carcinoma patients. CanGeriatr J 2014; 17: 83–87.Google ScholarPubMed
Ferreira, B C, Sá-Couto, P, Lopes, M C, Khouri, L. Compliance to radiation therapy of head and neck cancer patients and impact on treatment outcome. Clin Transl Oncol 2016; 18 (7): 677–684.CrossRefGoogle ScholarPubMed
Li, C I, Malone, K E, Daling, J R. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003; 163: 49–56.CrossRefGoogle ScholarPubMed
Peng, W, Chen, Y, Jiang, Q, Zheng, Y. Spatial analysis of hepatocellular carcinoma and socioeconomic status in China from a population-based cancer registry. Cancer Epidemiol 2010; 34: 29–33.CrossRefGoogle ScholarPubMed
Sharpe, K H, McMahon, A D, McClements, P, Watling, C, Brewster, D H, Conway, DI. Socioeconomic inequalities in incidence of lung and upper aero-digestive tract cancer by age, tumour subtype and sex: a population-based study in Scotland (2000–2007). Cancer Epidemiol 2012; 36: e164–e170.CrossRefGoogle Scholar
Parise, C A, Caggiano, V. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000–2010. BMC Cancer 2013; 13: 449.CrossRefGoogle Scholar
Jansen, L, Eberle, A, Emrich, K et al. Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer 2014; 134: 2951–2960.CrossRefGoogle ScholarPubMed
Dik, V K, Aarts, M J, Van Grevenstein, W M et al. Association between socioeconomic status, surgical treatment and mortality in patients with colorectal cancer. Br J Surg 2014; 101: 1173–1182.CrossRefGoogle ScholarPubMed